This patent covers a progenitor cell that gives rise to mesenchymal stem cells. The population appears to be highly expressing the marker STRO-1, capable of differentiating into fibroblasts, and have at least one of the following markers: THY-1, VCAM-1, STRO-2, and CD146.
These cells are claimed in this patent for augmentation of hematopoiesis.
It will be interesting to compare this patent to the Osiris family of mesenchymal stem cell patents.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.